This year's Alzheimer's Association International Conference, which took place in Toronto, Canada from July 27-31 featured a range of data readouts from companies developing in vitro diagnostics (IVD) ...

US Food and Drug Administration (FDA) commissioner Martin Makary has announced that the IV fluid shortage for sodium chloride 0.9% injection products is now over after nearly a year of disruption.

In the first half (H1) of 2025, Abbott Laboratories performed well in the US medical device sector, with steady growth in its core product lines.

The US FDA has granted approval to Nyxoah’s Genio system for treating individuals with moderate to severe obstructive sleep apnoea (OSA).

UK-based EDX Medical has developed a test designed to identify and characterise the early signs of pneumonia in critically ill hospitalised patients.

Dana-Farber Cancer Institute has unveiled a new blood test that could change the way multiple myeloma (MM) and its precursor conditions.

Boehringer and Click's CT-155 plus antipsychotics significantly reduced negative symptoms associated with schizophrenia in a Phase III trial ...

Zimmer has lifted its 2025 outlook due to growth in its sports medicine, extremities, trauma, craniomaxillofacial and thoracic business.

Natera has introduced a non-invasive prenatal test (NIPT), Fetal Focus, specifically designed for inherited conditions. According to the company, when a pregnant individual is found to carry a ...

HistoSonics has announced a majority stake acquisition by a consortium involving a transaction that values the company at $2.25bn.

China's NMPA has approved Bracco Imaging's ultrasound contrast agent, sulphur hexafluoride (SF6) microbubbles.

California-based startup Apreo Health has raised $130m to further the development of its implant for treating severe emphysema.